ADHD guidelines: NICE decision not to update
NICE response
Pharma and medical education
National Institute for Health and Clinical Excellence Review of Clinical Guideline (CG72) – Attention deficit hyperactivity disorder takeholder Comments Proforma Please enter the name of your registered stakeholder organisation below. NICE is unable to accept comments from non-registered organisation or individuals. If you wish your comments to be considered please register via the NICE website
Response of the Bradford Group to the Draft Outline Proposals of the Scoping Study Committee (143.55 kB 2010-12-08 09:52:19)
SURVEY OF CONSULTANT PSYCHIATRISTS_ A Brief Report
RESPONSE TO THE CONSULTATION DOCUMENT REFORM OF THE MENTAL HEALTH ACT 1983
MANAGING DANGEROUS PEOPLE WITH SEVERE PERSONALITY DISORDER
Evidence to the parliamentary inquiry on the influence of the pharmaceutical Industry_